Italy · research
Italy · researchResalis Therapeutics
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
PrivateFor profit
Against its peers
Set against 32 research companies in Italy. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 0% of those with a founding year.
About Resalis Therapeutics
BiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalProduct ResearchTherapeutics
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$26M
raised in total, currency not stated across 3 rounds
Last raised Jan 2024, 2 years ago
- Rounds
- 3
- Latest round
- Series a
- Investors
- 52 leading
Key facts
Who started it and how it trades.
- Founded by
- Riccardo Panella
Every detail we hold
Everything the source datasets list about Resalis Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Resalis Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Riccardo Panella
- Industry
- research
- Categories
- Biotechnology, Clinical Trials, Health Care, Medical, Pharmaceutical, Product Research, Therapeutics
Where3 fields
- City
- Turin
- Country
- Italy
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach1 field
- Staff band
- 1-10
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 26,000,000 (currency not stated)
- Rounds
- 3
- Latest round
- Series a
- Latest round date
- Jan 2024
- Investors
- 5
- Lead investors
- 2
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Resalis Therapeutics may be growing as it has successfully raised €10 million in a Series A funding round, which is a significant financial milestone for the company. This capital injection is intended to complete the first clinical trial for their product, RES-010, targeting obesity, indicating progress in their product development pipeline. Furthermore, the ability to secure such funding suggests investor confidence in the company's potential and its therapeutic solutions.
Companies like Resalis Therapeutics
research in Italy.
GenespireMilan · 1-10 peoplefounded 1 years earlier
Sibylla BiotechBresso · 11-50 peoplefounded 4 years earlier
Altheia ScienceMilan · 1-10 peoplefounded 4 years earlier
ALKemist BioTurin · 1-10 peoplefounded 2 years later
CanaxMilan · 1-10 peoplefounded 2 years earlier
Repron TherapeuticsMilan · 1-10 peoplefounded 2 years laterBuild a lead list
32 research companies in Italy, filtered by size, age and reach, ready to export with emails on Pro.